CLINICAL_TRIALS
trial_result
· 2026-04-13
Clinical Trial Update: CNGB1 and Allied Disorders
Summary
The CNGB1-related retinitis pigmentosa clinical trial has been suspended.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Columbia University | Conditions: Retinitis Pigmentosa Associated With CNGB1 Mutations | Status: SUSPENDED